Patents by Inventor Stephanie HOPLEY

Stephanie HOPLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-7 Binding Proteins and Their Use in Medical Therapy
    Publication number: 20240025988
    Abstract: Provided herein are interleukin 7 (IL-7) binding proteins, pharmaceutical compositions and their use in the treatment or prevention of a disease or condition.
    Type: Application
    Filed: September 5, 2023
    Publication date: January 25, 2024
    Applicant: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Gerben BOUMA, Edward Thomas COULSTOCK, David DIXON, Stephanie HOPLEY, Alan Peter LEWIS, Jessica Lynn NEISEN
  • ZIP12 ANTIBODY
    Publication number: 20230357387
    Abstract: The invention relates to ZIP12 antibodies. The invention extends to compositions comprising the antibodies, including pharmaceutical compositions and kits. The invention also extends to methods of making and using the antibodies, for example in therapy and diagnosis of hypoxia-related diseases, such as pulmonary hypertension and cancer.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 9, 2023
    Inventors: Stephanie HOPLEY, Paul HAMBLIN, Martin WILKINS, Lan ZHAO
  • IL-7 binding proteins and their use in medical therapy
    Patent number: 11802150
    Abstract: Provided herein are interleukin 7 (IL-7) binding proteins, pharmaceutical compositions and their use in the treatment or prevention of a disease or condition.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: October 31, 2023
    Assignee: GlaxoSmith Kline Intellectual Property Development Limited
    Inventors: Gerben Bouma, Edward Thomas Coulstock, David Dixon, Stephanie Hopley, Alan Peter Lewis, Jessica Lynn Neisen
  • IL-7 Binding Proteins and Their use in Medical Therapy
    Publication number: 20220169717
    Abstract: Provided herein are interleukin 7 (IL-7) binding proteins, pharmaceutical compositions and their use in the treatment or prevention of a disease or condition.
    Type: Application
    Filed: November 30, 2021
    Publication date: June 2, 2022
    Inventors: Gerben BOUMA, Edward Thomas Coulstock, David Dixon, Stephanie Hopley, Alan Peter Lewis, Jessica Lynn Neisen
  • COMPOUNDS AND METHODS FOR TUMOUR-SPECIFIC CELL DEPLETION
    Publication number: 20200283535
    Abstract: Described is a human IgG2 anti-CD25 antibody, wherein the antibody depletes CD25 cells, in particular tumour-infiltrating regulatory T cells. The antibody can be used in the treatment of cancer, for example in treating solid tumours and in haematological cancers.
    Type: Application
    Filed: July 6, 2018
    Publication date: September 10, 2020
    Applicants: Tusk Therapeutics Ltd., Cancer Research Technology Limited
    Inventors: Pascal MERCHIERS, Anne GOUBIER, Kevin MOULDER, Josephine SALIMU, Beatriz GOYENECHEA CORZO, Sergio QUEZADZ, Karl PEGGS, Frederick ARCE VARGAS, Isabelle SOLOMON, Joseph MABBITT, Stephanie HOPLEY